Thromb Haemost 2001; 86(03): 855-861
DOI: 10.1055/s-0037-1616143
Review Articles
Schattauer GmbH

Tissue Distribution of Factor VIII Gene Expression In Vivo – A Closer Look

Martine J. Hollestelle
1   Department of Blood Coagulation and Department of Plasma Proteins, CLB, Amsterdam, The Netherlands
,
Terri Thinnes
2   Department of Vascular Biology (VB-3), The Scripps Research Institute, La Jolla, CA, USA
,
Karen Crain
2   Department of Vascular Biology (VB-3), The Scripps Research Institute, La Jolla, CA, USA
,
Ann Stiko
2   Department of Vascular Biology (VB-3), The Scripps Research Institute, La Jolla, CA, USA
,
Johan K. Kruijt
3   Division of Biopharmaceutics, Leiden-Amsterdam Center for Drug Research, Sylvius Laboratories, Leiden
,
Theo J.C. van Berkel
3   Division of Biopharmaceutics, Leiden-Amsterdam Center for Drug Research, Sylvius Laboratories, Leiden
,
David J. Loskutoff
2   Department of Vascular Biology (VB-3), The Scripps Research Institute, La Jolla, CA, USA
,
Jan A. van Mourik
1   Department of Blood Coagulation and Department of Plasma Proteins, CLB, Amsterdam, The Netherlands
4   Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam
› Author Affiliations
Further Information

Publication History

Received 20 February 2001

Accepted after revision 13 April 2001

Publication Date:
14 December 2017 (online)

Summary

Previous studies have shown that factor VIII (FVIII) is expressed by multiple tissues. However, little is known about its cellular origin or its level of expression in different organs. In the present study, we examined FVIII gene expression in different tissues on a quantitative basis. Most of the tissues, especially liver and kidney, expressed high levels of FVIII mRNA compared to their level of expression of other hemostatic proteins, including von Willebrand factor (VWF). This was unexpected since FVIII is a trace protein. In situ hybridization analysis confirmed that liver and kidney were rich in FVIII mRNA. In the liver, a clear hybridization signal was detected in cells lining the sinusoids. FVIII mRNA analysis of purified liver cells confirmed the expression of FVIII mRNA by sinusoidal endothelial cells and Kupffer cells. Low but significant levels of FVIII mRNA were also detected in the hepatocytes. VWF mRNA was not detectable in these cells. Similarly, immunohistochemical staining of liver tissue revealed that FVIII protein is primarily associated with sinusoidal cells. VWF protein was predominantly located in the endothelium of larger vessels. In the kidney, FVIII synthesis was localized to the glomeruli and to tubular epithelial cells. Taken together, these results suggest that besides hepatocytes, non-parenchymal cells (e.g. sinusoidal endothelial cells) contribute to FVIII synthesis. VWF synthesis is primarily confined to extra-hepatic tissues.

 
  • References

  • 1 Mann KG. Biochemistry and physiology of blood coagulation. Thromb Haemost 1999; 82: 165-74.
  • 2 Lenting PJ, van Mourik JA, Mertens K. The life cycle of coagulation factor VIII in view of its structure and function. Blood 1998; 92: 3983-96.
  • 3 Schwarz HP, Lenting PJ, Binder B, Mihaly J, Denis C, Dorner F, Turecek PL. Involvement of low-density lipoprotein receptor-related protein (LRP) in the clearance of factor VIII in von Willebrand factor-deficient mice. Blood 2000; 95: 1703-8.
  • 4 Stel HV, van der Kwast TH, Veerman EC. Detection of factor VIII/coagulant antigen in human liver tissue. Nature 1983; 303: 530-2.
  • 5 Wion KL, Kelly D, Summerfield JA, Tuddenham EG, Lawn RM. Distribution of factor VIII mRNA and antigen in human liver and other tissues. Nature 1985; 317: 726-9.
  • 6 Zelechowska MG, van Mourik JA, Brodniewicz-Proba T. Ultrastructural localization of factor VIII procoagulant antigen in human liver hepatocytes. Nature 1985; 317: 729-30.
  • 7 Rall LB, Bell GI, Caput D, Truett MA, Masiarz FR, Najarian RC, Valenzuela P, Anderson HD, Din N, Hansen B. Factor VIII:C synthesis in the kidney [letter]. Lancet 1985; 1: 44.
  • 8 Levinson B, Kenwrick S, Gamel P, Fisher K, Gitschier J. Evidence for a third transcript from the human factor VIII gene. Genomics 1992; 14: 585-9.
  • 9 Elder B, Lakich D, Gitschier J. Sequence of the murine factor VIII cDNA. Genomics 1993; 16: 374-9.
  • 10 Bontempo FA, Lewis JH, Gorenc TJ, Spero JA, Ragni MV, Scott JP, Starzl TE. Liver transplantation in hemophilia A. Blood 1987; 69: 1721-4.
  • 11 Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
  • 12 Terpstra V, van Berkel TJ. Scavenger receptors on liver Kupffer cells mediate the in vivo uptake of oxidatively damaged red blood cells in mice. Blood 2000; 95: 2157-63.
  • 13 Yamamoto K, Loskutoff DJ. Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator. J Clin Invest 1996; 97: 2440-51.
  • 14 Yamamoto K, de WV, Fearns C, Loskutoff DJ. Tissue distribution and regulation of murine von Willebrand factor gene expression in vivo. Blood 1998; 92: 2791-801.
  • 15 Wang AM, Doyle MV, Mark DF. Quantitation of mRNA by the polymerase chain reaction [published erratum appears in Proc Natl Acad Sci USA 1990 Apr; 87(7): 2865]. Proc Natl Acad Sci USA 1989; 86: 9717-21.
  • 16 Yang TL, Cui J, Rehumtulla A, Yang A, Moussalli M, Kaufman RJ, Ginsburg D. The structure and function of murine factor V and its inactivation by protein C. Blood 1998; 91: 4593-9.
  • 17 Idusogie E, Rosen E, Geng JP, Carmeliet P, Collen D, Castellino FJ. Characterization of a cDNA encoding murine coagulation factor VII. Thromb Haemost 1996; 75: 481-7.
  • 18 Keeton M, Eguchi Y, Sawdey M, Ahn C, Loskutoff DJ. Cellular localization of type 1 plasminogen activator inhibitor messenger RNA and protein in murine renal tissue. Am J Pathol 1993; 142: 59-70.
  • 19 Donath MS, Lenting PJ, van Mourik JA, Mertens K. The role of cleavage of the light chain at positions Arg1689 or Arg1721 in subunit interaction and activation of human blood coagulation factor VIII. J Biol Chem 1995; 270: 3648-55.
  • 20 Webster WP, Mandel SR, Strike LE, Penick GD, Griggs TR, Brinkhous KM. Factor VIII synthesis: hepatic and renal allografts in swine with von Willebrand‘s disease. Am J Physiol 1976; 230: 1342-8.
  • 21 Koene RA, Gerlag PG, Jansen JL, Moulijn AC, Skotnicki SH, Debruyne FJ, Kunst VA, Geerdink P, Wijdeveld PG. Successful haemodialysis and renal transplantation in a patient with haemophilia A. Proc Eur Dial Transplant Assoc 1977; 14: 401-6.
  • 22 Lombardi R, Mannucci PM, Seghatchian MJ, Garcia VV, Coppola R. Alterations of factor VIII von Willebrand factor in clinical conditions associated with an increase in its plasma concentration. Br J Haematol 1981; 49: 61-8.
  • 23 Liu L, Xia S, Seifert J. Transplantation of spleen cells in patients with hemophilia A. A report of 20 cases. Transpl Int 1994; 7: 201-6.
  • 24 Veltkamp JJ, Asfaou E, Torren Kvd, Does vd JA, Tilburg Nv, Pauwels EK. Extrahepatic factor VIII synthesis. Lung transplants in hemophilic dogs. Transplantation 1974; 18: 56-62.
  • 25 Groth CG, Hathaway WE, Gustafsson A, Geis WP, Putnam CW, Bjorken C, Porter KA, Starzl TE. Correction of coagulation in the hemophilic dog by transplantation of lymphatic tissue. Surgery 1974; 75: 725-33.
  • 26 Yamamoto K, Loskutoff DJ. Extrahepatic expression and regulation of protein C in the mouse. Am J Pathol 1998; 153: 547-55.
  • 27 Seiffert D, Bordin GM, Loskutoff DJ. Evidence that extrahepatic cells express vitronectin mRNA at rates approaching those of hepatocytes. Histochem Cell Biol 1996; 105: 195-201.
  • 28 Swaroop M, Moussalli M, Pipe SW, Kaufman RJ. Mutagenesis of a potential immunoglobulin-binding protein-binding site enhances secretion of coagulation factor VIII. J Biol Chem 1997; 272: 24121-4.
  • 29 Do H, Healey JF, Waller EK, Lollar P. Expression of factor VIII by murine liver sinusoidal endothelial cells. J Biol Chem 1999; 274: 19587-92.